Marker Therapeutics, Inc. ( MRKR) - Key Metrics
MRKR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.07 | -$0.12 | -$0.16 | -$0.16 |
| 2025Q2 | $0.06 | -$0.29 | -$0.13 | -$0.13 |
| 2025Q1 | $0.03 | -$0.40 | -$0.50 | -$0.50 |
MRKR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.87 |
| 2025Q2 | ? | -1.33 |
| 2025Q1 | ? | -0.77 |
MRKR
Price: $1.33
52 week price:
Earnings Per Share: -0.55 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 156064
Market Capitalization: 15.3 million